K Thomas Bailey's Net Worth
$6.26 Million
Who is K Thomas Bailey?
K Thomas Bailey has an estimated net worth of $6.26 Million. This is based on reported shares across multiple companies, which include NanoString Technologies Inc, and ANGIOTECH PHARMACEUTICALS INC.
SEC CIK
K Thomas Bailey's CIK is 0001432055
Past Insider Trading and Trends
2021 was K Thomas Bailey's most active year for acquiring shares with 14 total transactions. K Thomas Bailey's most active month to acquire stocks was the month of February. 2021 was K Thomas Bailey's most active year for disposing of shares, totalling 29 transactions. K Thomas Bailey's most active month to dispose stocks was the month of February. 2020 saw K Thomas Bailey paying a total of $506,576.70 for 93,780 shares, this is the most they've acquired in one year. In 2021 K Thomas Bailey cashed out on 99,799 shares for a total of $3,839,960.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NanoString Technologies Inc (NSTG) No price found
Chief Financial OfficerK Thomas Bailey owns 304,163 units of Common Stock. From 2018 to 2024 K Thomas Bailey acquired a total of 509,461 shares in NanoString Technologies Inc at a cost of $1,538,681.17, K also disposed a total of 202,533 shares of NanoString Technologies Inc equalling to $7,794,064.85.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +150.42% | 182.7K |
—
|
—
| 304.16K |
May 6
| |||
Form 4
| +61.11% | 46.07K |
—
|
—
| 121.46K |
Mar 5
| |||
Form 4
| +24.84% | 15K |
$5.76 | $86,445.00 | 75.39K |
May 26
| |||
Form 4
| +18.93% | 9.61K |
$10.16 | -$67,045.84 | 60.39K |
Mar 4 - Mar 6
| |||
Form 4
| +4.62% | 2.24K |
$10.39 | -$18,795.51 | 50.77K |
Jan 26
| |||
Form 4
| +150.53% | 29.16K |
$8.05 | $234,746.05 | 48.53K |
Dec 13
| |||
Form 4
| +20.29% | 3.27K |
$27.81 | -$58,674.88 | 19.37K |
Mar 14 - Mar 15
| |||
Form 4
| -23.69% | -5.00K |
$33.81 | -$169,050.00 | 16.11K |
Mar 10
| |||
Form 4
| +28.61% | 4.7K |
$33.06 | -$101,109.71 | 21.11K |
Mar 6 - Mar 8
| |||
Form 4
| +163.87% | 10.19K |
$31.00 | -$109,058.00 | 16.41K |
Jan 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
∞
| 6.22K |
$31.99 | -$64,075.97 | 6.22K |
Jan 26
| |||
Form 4
|
—
|
0
|
$29.30 | -$273,647.72 |
0
|
Scheduled
|
Nov 17
| ||
Form 4
|
—
|
0
|
$31.92 | -$314,812.65 |
0
|
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$31.48 | -$205,254.70 |
0
|
Scheduled
|
May 18
| ||
Form 4
| -6.01% | -1.16K |
$66.32 | -$76,997.52 | 18.16K |
Mar 16
| |||
Form 4/A
| +26.45% | 4.04K |
$66.32 | -$88,537.20 | 19.32K |
Mar 15 - Mar 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -18.16K |
$38.74 | -$1,753,988.37 |
0
|
Scheduled
|
Mar 17
| ||
Form 4
| +28.87% | 4.04K |
$66.32 | -$88,537.20 | 18.04K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +36.08% | 3.71K |
$60.33 | -$76,981.08 | 14K |
Mar 5 - Mar 9
| |||
Form 4
|
∞
| 10.29K |
$63.59 | -$217,668.57 | 10.29K |
Jan 27
| |||
Form 4
|
—
|
0
|
$33.07 | -$542,851.54 |
0
|
Scheduled
|
Nov 18 - Nov 19
| ||
Form 4
|
—
|
0
|
$23.55 | -$182,774.98 |
0
|
Scheduled
|
Aug 18
| ||
Form 4
| -100.00% | -3.26K |
$29.17 | -$95,104.96 |
0
|
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$20.01 | -$140,683.62 | 3.26K |
Scheduled
|
May 18
| ||
Form 4
|
∞
| 3.26K |
$19.53 | -$41,325.48 | 3.26K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
$19.81 | -$184,581.82 |
0
|
Scheduled
|
Mar 10
| ||
Form 4
| -100.00% | -25.87K |
$28.10 | -$727,075.64 |
0
|
Scheduled
|
Feb 3
| ||
Form 4
|
∞
| 25.87K |
$30.84 | -$281,507.52 | 25.87K |
Jan 16
| |||
Form 4
|
—
|
0
|
$15.58 | -$88,108.05 |
0
|
Scheduled
|
Nov 12
| ||
Form 4
|
—
|
0
|
$16.70 | -$608,326.20 |
0
|
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16 - Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANGIOTECH PHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -100.00% | -30.00K |
—
|
—
|
0
|
May 12
| |||
Form 4
| -100.00% | -30.00K |
$1.67 | -$50,089.00 |
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 30K |
$1.67 | $50,089.00 | 30K |
Aug 17 - Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||